Advocacy & Compliance

Healthesystems’ Advocacy & Compliance experts are essential in the management of pharmacy and ancillary benefits for our clients. By tracking and influencing regulatory activity, our team stays ahead of evolving trends and identifies opportunities to advocate on behalf of our clients, their injured workers, and the broader industry.

Go to Regulatory Recap News

Subscribe for Weekly Updates

The Advocacy &  Compliance Team

Monitors and reports on proposed and pending regulatory changes that impact workers' comp, helping shape effective program strategies

Advocates for fair and balanced public policy through proactive engagement with regulators, customers, and other stakeholders throughout the rulemaking lifecycle

Supports operational compliance by providing guidance to internal stakeholders and external partners during the implementation of new regulatory changes

Regulatory Recap

A weekly e-newsletter informed by the Advocacy & Compliance team to help keep our clients and industry contacts in the know on the latest legislation and policy updates impacting workers’ comp.

Subscribe

Mental Health Psychedelics

Illinois Introduces Psilocybin Therapy Bill

Along with the supervised therapeutic use, the bill would implement a sales tax, public education, and much more.

Read More →

February 17, 2025

California Proposes Updates to Medical Treatment Utilization Schedule

The updates would incorporate evidence-based revisions to Chronic Pain Guidelines and Cannabis Guidelines from ACOEM.

Read More →

February 17, 2025

Claim Costs Industry Data

NCCI Publishes Mega Claims Report

Mega claims – with losses over $2 million – represent less than 0.1% of claims, but over 2% of total loss dollars.

Read More →

February 10, 2025

Claim Costs Industry Data

NCCI Releases Medical Inflation Report

The report the rising cost of physician services, the largest category of medical spending in workers’ comp.

Read More →

February 10, 2025

Access to Care

Kansas Introduces Provider Choice Bill

Injured workers would be allowed to select their provider, and language allowing regulators to select new providers would be removed.

Read More →

February 10, 2025

Alternative Therapy

New Mexico, New York, & Oregon Consider Chiropractor and Acupuncturist Bills

These bills would grant more authority to these practitioners, in one case letting them prescribe and administer prescription drugs.

Read More →

February 10, 2025

Access to Care

WCRI Reports on Changes in The Medical Workforce

The provider shortage increased during the pandemic, but a shift to advanced practitioners saw minimal impacts to claims costs and other metrics.

Read More →

February 3, 2025

Psychedelics

Ketamine Therapy Bills in Hawaii, Missouri, & Texas

Hawaii considers partial coverage, Missouri wants stricter guidelines, & Texas proposes a grant program for military and first responders.

Read More →

February 3, 2025

Presumptions

Florida Bills Could Clarify Heart Disease Presumption for First Responders

Statutes from 1965 did not define what constitutes “heart disease” and these new bills would provide definitions that expand the presumption.

Read More →

February 3, 2025

« Previous 1 … 27 28 29 30 31 … 43 Next »

Subscribe to Regulatory Recap

Get weekly legislation & policy updates straight to your inbox.

hello world!

Further resources you may be interested in

Additional articles and updates from Healthesystems related to policy shaping workers’ comp.

COVID-19 Mutations Impact Testing

False negatives may be reported due to genetic variations of the virus.

Worker Classification Debate Continues Across the Country

The Department of Labor issued a new rule while special interest groups push for regulatory change.

The Department of Justice Sues Walmart Over Role in Opioid Crisis

Alleged violations of the Controlled Substances Act could result in billions of dollars in penalties.

Top 10 Disruptors of 2020 for the Workers’ Comp Industry

Initial insights from Healthesystems’ annual industry survey.

FDA Authorizes Two COVID-19 Vaccines, At-Home Test, More Treatments

Vaccine candidates from Pfizer-BioNTech and Moderna received EUAs, as did the first at-home test that delivers results in 30 minutes, and two treatments for the virus.